The use of inhaled corticosteroids in the wheezy under 5-year-old child

Archives of Disease in Childhood: Education and Practice Edition

Volumn 96, Issue 2, 2011, Pages 61-66

  Davies, B R ^a   Carroll, W D ^b  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b DERBYSHIRE CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; FLUTICASONE; FLUTICASONE PROPIONATE; MOMETASONE FUROATE; MONTELUKAST; NEDOCROMIL; PREDNISOLONE; SHORT ACTING DRUG; STEROID;

ADRENAL CORTEX INSUFFICIENCY; ADRENAL SUPPRESSION; ASTHMA; CANDIDIASIS; CATARACT; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONSENSUS; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; FRACTURE; GROWTH RATE; GROWTH RETARDATION; HOARSENESS; HUMAN; INHALER; LONG TERM CARE; MOUTH DISEASE; PATIENT COMPLIANCE; PHARYNX DISEASE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SIDE EFFECT; TREATMENT OUTCOME; WHEEZING;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHILD, PRESCHOOL; EVIDENCE-BASED MEDICINE; EXPERT TESTIMONY; HUMANS; RESPIRATORY SOUNDS;

EID: 79952797860     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/adc.2009.171272     Document Type: Review

References (62)

1. Bisgaard H, Szefler S. Prevalence of asthma-like symptoms in young children. Pediatr Pulmonol 2007;42:723-8. (Pubitemid 47242870)
2. Anderson HR, Gupta R, Strachan DP, et al. 50 years of asthma: UK trends from 1955 to 2004. Thorax 2007;62:85-90.
3. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133-8.
4. Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003;349:1414-22. (Pubitemid 37211056)
5. Castro-Rodríguez JA, Holberg CJ, Wright AL, et al. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000;162:1403-6.
6. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2008. http://www.ginasthma.org/ (Accessed 20 September 2009).
7. Brand PL, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008;32:1096-110.
8. Frey U, von Mutius E. The challenge of managing wheezing in infants. N Engl J Med 2009;360:2130-3.
9. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. http://www.sign.ac.uk/guidelines/ fulltext/101/index.html (Accessed 20 September 2009).
10. Saglani S, Malmström K, Pelkonen AS, et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005;171:722-7. (Pubitemid 40471142)
11. Global Initiative for Asthma. Global Strategy for the Diagnosis and Management of Asthma in Children 5 Years And Younger. 2009. http://www. ginasthma.org/ (Accessed 20 September 2009).
12. Henderson J, Granell R, Sterne J. The search for new asthma phenotypes. Arch Dis Child 2009;94:333-6.
13. Lenney W, Boner AL, Bont L, et al. Medicines used in respiratory diseases only seen in children. Eur Respir J 2009;34:531-51.
14. Papadopoulos NG, Kalobatsou A. Respiratory viruses in childhood asthma. Curr Opin Allergy Clin Immunol 2007;7:91-5. (Pubitemid 46095892)
15. Anderson M, Carroll W. Virus vaccines and children with asthma. Curr Opin Allergy Clin Immunol 2009;9:44-9.
16. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541-5. (Pubitemid 29381367)
17. Gelfand EW. Pediatric asthma: a different disease. Proc Am Thorac Soc 2009;6:278-82.
18. Khetsuriani N, Kazerouni NN, Erdman DD, et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol 2007;119:314-21. (Pubitemid 46204808)
19. Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008;178:667-72.
20. Johnston NW, Johnston SL, Duncan JM, et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol 2005;115:132-8. (Pubitemid 40075433)
21. Murray CS, Poletti G, Kebadze T, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006;61:376-82. (Pubitemid 43723318)
22. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006;354:1985-97.
23. Kaditis AG, Winnie G, Syrogiannopoulos GA. Anti-inflammatory pharmacotherapy for wheezing in preschool children. Pediatr Pulmonol 2007;42:407-20. (Pubitemid 46700939)
24. Bisgaard H, Hermansen MN, Loland L, et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006;354:1998-2005.
25. Bacharier LB, Phillips BR, Zeiger RS, et al. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol 2008;122:1127-1135.e8.
26. Bacharier LB, Guilbert TW, Zeiger RS, et al. Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma. J Allergy Clin Immunol 2009;123:1077-82, 1082. e1-5.
27. Ducharme FM, Lemire C, Noya FJ, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med 2009;360:339-53.
28. van Staa TP, Cooper C, Leufkens HG, et al. Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res 2003;18:913-8. (Pubitemid 37294976)
29. Liu AH, Zeiger R, Sorkness C, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 2007;119:817-25. (Pubitemid 46527825)
30. Mak JC, Nishikawa M, Barnes PJ. Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am J Physiol 1995;268:L41-6.
31. O'Connor BJ, Ridge SM, Barnes PJ, et al. Greater effect of inhaled budesonide on adenosine 5′-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma. Am Rev Respir Dis 1992;146:560-4.
32. Gibson PG, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial. Am J Respir Crit Care Med 2001;163:32-6. (Pubitemid 32095249)
33. Spoelstra FM, Postma DS, Hovenga H, et al. Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts. Eur Respir J 2000;15:68-74. (Pubitemid 30068938)
34. Bush A. Practice imperfect - treatment for wheezing in preschoolers. N Engl J Med 2009;360:409-10.
35. Schüepp KG, Devadson S, Roller C, et al. A complementary combination of delivery device and drug formulation for inhalation therapy in preschool children. Swiss Med Wkly 2004;134:198-200. (Pubitemid 38529383)
36. Falcoz C, Oliver R, McDowall JE, et al. Bioavailability of orally administered micronised fluticasone propionate. Clin Pharmacokinet 2000;39:9-15.
37. Kelly HW. Comparison of inhaled corticosteroids: an update. Ann Pharmacother 2009;43:519-27.
38. Kaliner MA. Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: a comparison of ciclesonide and fluticasone propionate. Clin Ther 2006;28:319-31. (Pubitemid 43783434)
39. Conn KM, Halterman JS, Fisher SG, et al. Parental beliefs about medications and medication adherence among urban children with asthma. Ambul Pediatr 2005;5:306-10. (Pubitemid 41419148)
40. Jónasson G, Carlsen KH, Mowinckel P. Asthma drug adherence in a long term clinical trial. Arch Dis Child 2000;83:330-3.
41. Onhøj J, Thorsson L, Bisgaard H. Lung deposition of inhaled drugs increases with age. Am J Respir Crit Care Med 2000;162:1819-22.
42. Bisgaard H, Gillies J, Groenewald M, et al. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study. Am J Respir Crit Care Med 1999;160:126-31. (Pubitemid 29326077)
43. Gulliver T, Morton R, Eid N. Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations. Paediatr Drugs 2007;9:185-94. (Pubitemid 46849138)
44. Schueepp KG, Devadason SG, Roller C, et al. Aerosol delivery of nebulised budesonide in young children with asthma. Respir Med 2009;103:1738-45.
45. Allen DB. Limitations of short-term studies in predicting long-term adverse effects of inhaled corticosteroids. Allergy 1999;54:29-34. (Pubitemid 29292490)
46. Sharek PJ, Bergman DA. Beclomethasone for asthma in children: effects on linear growth. Cochrane Database Syst Rev 2000;2:CD001282.
47. Marshall WA. Evaluation of growth rate in height over periods of less than one year. Arch Dis Child 1971;46:414-20.
48. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000;343:1054-63.
49. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000;343:1064-9.
50. Pedersen S. Do inhaled corticosteroids inhibit growth in children? Am J Respir Crit Care Med 2001;164:521-35. (Pubitemid 32807684)
51. Bisgaard H, Allen D, Milanowski J, et al. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics 2004;113:e87-94.
52. Todd GR. Side-effects of high-dose fluticasone propionate in children. Eur Respir J 1999;13:707-9. (Pubitemid 29180192)
53. Schlienger RG, Jick SS, Meier CR. Inhaled corticosteroids and the risk of fractures in children and adolescents. Pediatrics 2004;114:469-73. (Pubitemid 39006677)
54. Roux C, Kolta S, Desfougères JL, et al. Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma. Pediatrics 2003;111:e706-13.
55. Agertoft L, Pedersen S. Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide. Am J Respir Crit Care Med 1998;157:178-83. (Pubitemid 28071280)
56. Efthimiou J, Barnes PJ. Effect of inhaled corticosteroids on bones and growth. Eur Respir J 1998;11:1167-77. (Pubitemid 28281040)
57. Todd GR, Acerini CL, Ross-Russell R, et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002;87:457-61. (Pubitemid 35440691)
58. Gold DR, Fuhlbrigge AL. Inhaled corticosteroids for young children with wheezing. N Engl J Med 2006;354:2058-60.
59. Llapur CJ, Martínez TM, Coates C, et al. Lung structure and function of infants with recurrent wheeze when asymptomatic. Eur Respir J 2009;33:107-12.
60. Bush A. Asthma research: the real action is in children. Paediatr Respir Rev 2005;6:101-10. (Pubitemid 40692047)
61. Bush A. COPD: a pediatric disease. COPD 2008;5:53-67. (Pubitemid 351225517)
62. Kovar J, Willet KE, Hislop A, et al. Impact of postnatal glucocorticoids on early lung development. J Appl Physiol 2005;98:881-8. (Pubitemid 40283668)